Page last updated: 2024-09-04

irofulven and Astrocytoma, Grade IV

irofulven has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Billups, C; Cheshire, PJ; Fouladi, M; Friedman, HS; Houghton, PJ; Leggas, M; Peterson, JK; Stewart, CF; Woo, MH1
Bigner, DD; Friedman, HS; Houghton, PJ; Keir, ST; Lawless, AA; Waters, SJ1

Other Studies

2 other study(ies) available for irofulven and Astrocytoma, Grade IV

ArticleYear
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chromatography, High Pressure Liquid; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Medulloblastoma; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Mice, SCID; Neoplasms; Neuroblastoma; Neuroectodermal Tumors, Primitive; Radiation Chimera; Random Allocation; Rhabdoid Tumor; Rhabdomyosarcoma, Embryonal; Sesquiterpenes; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays

2002
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic mice.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:5

    Topics: Animals; Antineoplastic Agents, Alkylating; Female; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Sesquiterpenes; Transplantation, Heterologous

2001